There are several drugs for AD that have been licensed by the FDA, such as cholinesterase inhibitors (e.g., rivastigmine and donepezil) as well as NMDA receptor antagonists (e.g., memantine), However, they have limited benefits on severe cognitive impairment and cannot reverse the course of the condition [25,26,27]. Here, BCHE is linked to Alzheimer disease.